Status:
UNKNOWN
Effect of Ginseng on Glycemic Control
Lead Sponsor:
Unity Health Toronto
Conditions:
Impaired Glucose Tolerance
Diabetes
Eligibility:
All Genders
Brief Summary
Ginseng (American ginseng, Asian ginseng, Korean ginseng etc) is expected to show positive hypoglycemic effects, including improvements in glycated blood proteins\[HbA1c\], fasting glucose, fasting in...
Detailed Description
Ginseng has demonstrated to have significant hypoglycemic effect. Its major pharmacological component is considered to be ginsenosides. Several trials have been undertaken in diabetes some of which ha...
Eligibility Criteria
Inclusion
- Dietary trials in humans
- Randomized treatment allocation
- 1 month
- Suitable control
- Viable endpoint data
Exclusion
- Non-human studies
- Non-randomized treatment allocation
- \<1 month
- Lack of a suitable control
- No viable endpoint data
Key Trial Info
Start Date :
October 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
770 Patients enrolled
Trial Details
Trial ID
NCT01841229
Start Date
October 1 2012
End Date
May 1 2013
Last Update
May 23 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Toronto 3D Knowledge Synthesis and Clinical trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St.Michael's Hospital.
Toronto, Ontario, Canada, M5C 2T2